21 May 2026
Reshaping what's possible in complex PCI with advanced sirolimus technology
Sponsored by Cordis
Anchorperson:
P. O'Kane
Summary
Focused on advancing complex PCI, this session explores strategies to minimise metal use through advanced sirolimus technologies and drug-coated balloon (DCB) therapies. It highlights the biological and pharmacokinetic characteristics of DCBs, key device design considerations, and practical approaches to less-metal PCI. Clinical cases illustrate challenges such as tortuous anatomy and long, diffuse disease, with guidance on vessel healing and the management of dissections.
Learning Objectives
- To understand the value of minimising metal in complex PCI, and the role of drug biology and device design
- To discuss how DCB technologies differ in drug characteristics and biological effects, including pharmacokinetics, vessel healing, and lumen durability
- To apply practical decision-making for less‑metal PCI, including deliverability, dissection management, and patient and lesion selection
